PMID- 28089201
OWN - NLM
STAT- MEDLINE
DCOM- 20180716
LR  - 20180716
IS  - 1523-1747 (Electronic)
IS  - 0022-202X (Linking)
VI  - 137
IP  - 3
DP  - 2017 Mar
TI  - Recent Advances in Melanoma and Melanocyte Biology.
PG  - 557-560
LID - S0022-202X(16)32640-9 [pii]
LID - 10.1016/j.jid.2016.11.004 [doi]
FAU - Tsao, Hensin
AU  - Tsao H
AD  - Department of Dermatology, Wellman Center for Photomedicine, Massachusetts
      General Hospital, Boston, Massachusetts, USA. Electronic address:
      htsao@partners.org.
FAU - Fukunaga-Kalabis, Mizuho
AU  - Fukunaga-Kalabis M
AD  - Molecular and Cellular Oncogenesis Program and Melanoma Research Center, The
      Wistar Institute, Philadelphia, Pennsylvania, USA.
FAU - Herlyn, Meenhard
AU  - Herlyn M
AD  - Molecular and Cellular Oncogenesis Program and Melanoma Research Center, The
      Wistar Institute, Philadelphia, Pennsylvania, USA. Electronic address:
      herlynm@wistar.org.
LA  - eng
GR  - K24 CA149202/CA/NCI NIH HHS/United States
GR  - P30 CA010815/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Review
DEP - 20170112
PL  - United States
TA  - J Invest Dermatol
JT  - The Journal of investigative dermatology
JID - 0426720
RN  - 0 (Biomarkers, Tumor)
SB  - IM
MH  - Animals
MH  - Biomarkers, Tumor/*metabolism
MH  - Combined Modality Therapy
MH  - Humans
MH  - Melanocytes/*metabolism
MH  - *Melanoma/metabolism/pathology/therapy
MH  - *Skin Neoplasms/metabolism/pathology/therapy
EDAT- 2017/01/17 06:00
MHDA- 2018/07/17 06:00
CRDT- 2017/01/17 06:00
PHST- 2016/11/02 00:00 [received]
PHST- 2016/11/03 00:00 [accepted]
PHST- 2017/01/17 06:00 [pubmed]
PHST- 2018/07/17 06:00 [medline]
PHST- 2017/01/17 06:00 [entrez]
AID - S0022-202X(16)32640-9 [pii]
AID - 10.1016/j.jid.2016.11.004 [doi]
PST - ppublish
SO  - J Invest Dermatol. 2017 Mar;137(3):557-560. doi: 10.1016/j.jid.2016.11.004. Epub 
      2017 Jan 12.